Burton E. Appel

Pediatric Hematology Oncology

61 Davis Avenue
Suite 1
Neptune, NJ 7753.

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Journey to a Fertility Preservation Program: For the Next Generation.

Journey to a Fertility Preservation Program: For the Next Generation.

Journal: Pediatric blood & cancer

Published: April 07, 2026

Checkpoint Inhibitor Pneumonitis With Pneumomediastinum Following Nivolumab-AVD in Classic Hodgkin Lymphoma: A Case Report.

Checkpoint Inhibitor Pneumonitis With Pneumomediastinum Following Nivolumab-AVD in Classic Hodgkin Lymphoma: A Case Report.

Journal: Journal of pediatric hematology/oncology

Published: November 21, 2025

Childhood cancer survivors and their caregivers are amenable to survivorship surveillance with community-based primary care providers.

Childhood cancer survivors and their caregivers are amenable to survivorship surveillance with community-based primary care providers.

Journal: Journal of cancer survivorship : research and practice

Published: September 12, 2025

A Children's Oncology Group Survey Exploring Practices and Barriers to Sperm Banking for Post-Pubertal Males with Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia.

A Children's Oncology Group Survey Exploring Practices and Barriers to Sperm Banking for Post-Pubertal Males with Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia.

Journal: Journal of adolescent and young adult oncology

Published: July 28, 2025

Increasing Physical Activity in Children During Cancer Treatment: A Qualitative Study of Parents' Perspectives.

Increasing Physical Activity in Children During Cancer Treatment: A Qualitative Study of Parents' Perspectives.

Journal: Pediatric blood & cancer

Published: March 19, 2025

Parental perspectives on the use of tumor molecular profiling and germline genetic testing during their children's cancer treatment.

Parental perspectives on the use of tumor molecular profiling and germline genetic testing during their children's cancer treatment.

Journal: Familial cancer

Published: December 07, 2024

Design and methods of a multi-level intervention to improve adherence to childhood cancer survivorship care by partnering with primary care providers: The BRIDGES randomized controlled trial.

Design and methods of a multi-level intervention to improve adherence to childhood cancer survivorship care by partnering with primary care providers: The BRIDGES randomized controlled trial.

Journal: Contemporary clinical trials

Published: November 27, 2024

Patient Characteristics and Neighborhood-Level Social Determinants of Health Associated With Childhood Cancer Survivor Follow-Up at Urban Cancer Centers.

Patient Characteristics and Neighborhood-Level Social Determinants of Health Associated With Childhood Cancer Survivor Follow-Up at Urban Cancer Centers.

Journal: Pediatric blood & cancer

Published: November 13, 2024

PET Response and Outcome in Low-Risk Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1.

PET Response and Outcome in Low-Risk Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1.

Journal: Pediatric blood & cancer

Published: November 12, 2024

Multilevel Facilitators and Barriers to Healthcare Organization and Delivery Among Childhood Cancer Survivors.

Multilevel Facilitators and Barriers to Healthcare Organization and Delivery Among Childhood Cancer Survivors.

Journal: Pediatric blood & cancer

Published: August 05, 2024

Hyperinsulinism-induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)-rywn chemotherapy in a pediatric AML patient.

Hyperinsulinism-induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)-rywn chemotherapy in a pediatric AML patient.

Journal: Pediatric blood & cancer

Published: January 24, 2024

Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).

Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).

Journal: Leukemia & lymphoma

Published: March 31, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026